Prevalence of transactive response DNA-binding protein 43 (TDP-43) proteinopathy in cognitively normal older adults: systematic review and meta-analysis
Carregando...
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
HOKKANEN, S. R. K.
HUNTER, S.
KEAGE, H.
Citação
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, v.44, n.3, p.286-297, 2018
Resumo
ObjectiveTo perform a systematic review and meta-analysis on the prevalence of transactive response DNA-binding protein 43 (TDP-43) proteinopathy in cognitively normal older adults. MethodsWe systematically reviewed and performed a meta-analysis on the prevalence of TDP-43 proteinopathy in older adults with normal cognition, evaluated by the Mini-Mental State Examination or the Clinical Dementia Rating. We estimated the overall prevalence of TDP-43 using random-effect models, and stratified by age, sex, sample size, study quality, antibody used to assess TDP-43 aggregates, analysed brain regions, Braak stage, Consortium to Establish a Registry for Alzheimer's Disease score, hippocampal sclerosis and geographic location. ResultsA total of 505 articles were identified in the systematic review, and 7 were included in the meta-analysis with 1196 cognitively normal older adults. We found an overall prevalence of TDP-43 proteinopathy of 24%. Prevalence of TDP-43 proteinopathy varied widely across geographic location (North America: 37%, Asia: 29%, Europe: 14%, and Latin America: 11%). Estimated prevalence of TDP-43 proteinopathy also varied according to study quality (quality score >7: 22% vs. quality score <7: 42%), antibody used to assess TDP-43 proteinopathy (native: 18% vs. hyperphosphorylated: 24%) and presence of hippocampal sclerosis (without 24% vs. with hippocampal sclerosis: 48%). Other stratified analyses by age, sex, analysed brain regions, sample size and severity of AD neuropathology showed similar pooled TDP-43 prevalence. ConclusionsDifferent methodology to access TDP-43, and also differences in lifestyle and genetic factors across different populations could explain our results. Standardization of TDP-43 measurement, and future studies about the impact of genetic and lifestyle characteristics on the development of neurodegenerative diseases are needed.
Palavras-chave
brain ageing, dementia, elderly, post mortem, TDP-43 proteinopathy
Referências
- Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x
- Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018
- Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373
- Arnold SJ, 2013, ACTA NEUROPATHOL, V126, P51, DOI 10.1007/s00401-013-1110-0
- BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
- Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6
- Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0
- Brettschneider J, 2015, ACTA NEUROPATHOL, V129, P929, DOI 10.1007/s00401-015-1428-x
- Brettschneider J, 2014, ACTA NEUROPATHOL, V127, P423, DOI 10.1007/s00401-013-1238-y
- Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937
- Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269
- Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2
- Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986
- Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x
- Cykowski MD, 2016, J NEUROPATH EXP NEUR, V75, P397, DOI 10.1093/jnen/nlw014
- Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005
- Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
- Elobeid A, 2014, ALZHEIMERS DEMENT, V10, P522, DOI 10.1016/j.jalz.2012.12.009
- Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901
- Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b
- FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
- Geser F, 2011, PROG NEUROBIOL, V95, P649, DOI 10.1016/j.pneurobio.2011.08.011
- Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558
- Goossens J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0195-1
- Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3
- Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425
- Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
- Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002
- Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003
- James BD, 2016, BRAIN
- Edition JBIRM, 2014, JOANN BRIGGS I REV M
- Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048
- Josephs KA, 2016, NEUROPATH APPL NEURO, V42, P390, DOI 10.1111/nan.12309
- Josephs KA, 2014, ACTA NEUROPATHOL, V127, P811, DOI 10.1007/s00401-014-1269-z
- Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9
- Keage HAD, 2014, J ALZHEIMERS DIS, V42, P641, DOI 10.3233/JAD-132351
- Kivipelto M, 2001, BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447
- Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
- Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087
- Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y
- Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498
- Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
- Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014
- Markesbery WR, 2009, J NEUROPATH EXP NEUR, V68, P816, DOI 10.1097/NEN.0b013e3181ac10a7
- Mayeda ER, 2014, DIABETES CARE, V37, P1009, DOI 10.2337/dc13-0215
- MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
- Mizuno Y, 2012, J NEUROL SCI, V315, P20, DOI 10.1016/j.jns.2011.12.012
- Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825
- MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
- Morris MC, 2012, P NUTR SOC, V71, P1, DOI 10.1017/S0029665111003296
- Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388
- Nascimento C, 2016, BRAIN PATHOL, V26, P177, DOI 10.1111/bpa.12296
- Nelson PT, 2016, J NEUROPATH EXP NEUR, V75, P482, DOI 10.1093/jnen/nlw033
- Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
- Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
- Paganini-Hill A, 2016, ALZ DIS ASSOC DIS, V30, P21, DOI 10.1097/WAD.0000000000000087
- Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002
- Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P352, DOI 10.1007/s13311-015-0338-x
- Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647
- Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
- Sterne JAC, 2008, SYSTEMATIC REV HLTH, P347, DOI 10.1002/9780470693926.CH18
- Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
- Tan RH, 2015, BRAIN, V138, P3110, DOI 10.1093/brain/awv220
- Tan RH, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-33
- Uchino A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0215-1
- Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961
- Yu L, 2015, NEUROLOGY, V84, P927, DOI 10.1212/WNL.0000000000001313
- Zhao BN, 2015, AM J HYPERTENS, V28, P631, DOI 10.1093/ajh/hpu189
Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/15
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/15